Home » Topics » BioWorld Science

BioWorld Science
RSS

Beta Pharma synthesizes new FGFR inhibitors

Aug. 11, 2021

Mindset presents preclinical data for next-generation psychedelic drug families

Aug. 11, 2021

New MAP4K1 inhibitors identified at Blueprint Medicines

Aug. 11, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents BCR-ABL inhibitors

Aug. 11, 2021

New PSMB8 inhibitors divulged by Shouyao Holdings

Aug. 11, 2021

Final topline data presented from DeCidE1 study of MVP-S in ovarian cancer

Aug. 11, 2021

Resveratrol-triggered switches maximize cancer immunotherapy, reduce toxicity

Aug. 11, 2021

Second interim analysis data from phase IIa study of vilobelimab in pyoderma gangrenosum

Aug. 11, 2021

First patient dosed in phase I study of APL-102

Aug. 10, 2021

Ohio State University describes looped proteins comprising cell-penetrating peptides

Aug. 10, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...